STOCK TITAN

Bluerock Acquisition Corp. Unit 8-K Filings

BLRKU NASDAQ

Every 8-K that Bluerock Acquisition Corp. Unit (BLRKU) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow BLRKU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BLRKU filings page.

Rhea-AI Summary

Bluerock Acquisition Corp. agreed to merge with Bitonic Technology Labs Inc. d/b/a Yellow.ai, taking Yellow.ai public on Nasdaq under the name “Yellow.ai.” The deal values Yellow.ai at approximately $300 million pre-money and implies about $550 million of pro forma equity value, assuming no redemptions.

Before closing, Bluerock will domesticate from Cayman to Delaware, with all Class A and B ordinary shares, warrants and units converting into equivalent Pubco common stock, warrants and units. Yellow.ai shareholders will receive Pubco shares based on $300,000,000 divided by $10.00, allocated across fully diluted Yellow.ai equity.

Financing includes an equity PIPE for 500,000 Pubco units at $10.00 each and a Note PIPE for up to $50,000,000 of senior secured convertible notes bearing 12% interest (18% on default) and initially convertible at $10.00 per share, subject to reset and a 9.99% beneficial ownership cap. A 2026 Milestone Equity Plan can issue up to 17,500,000 Pubco shares on revenue- and price-based triggers, and an additional equity plan will initially reserve 10% of post-close fully diluted shares. The sponsor will support the transaction, forfeit 750,000 founder shares and 2,000,000 warrants, and transfer up to 1,000,000 shares to PIPE investors. There is no minimum cash condition, and closing is targeted for the second half of 2026, subject to shareholder approvals and customary conditions.

Rhea-AI Summary

Bluerock Acquisition Corp. announced that holders of its units can elect to separately trade the Class A ordinary shares and warrants included in those units starting on or about February 2, 2026. Each unit consists of one Class A ordinary share with a par value of $0.0001 and one-third of one redeemable warrant, with each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share.

Units will continue to trade on the Nasdaq Global Market under the symbol BLRKU, while the separated Class A ordinary shares and warrants will trade under BLRK and BLRKW, respectively. No fractional warrants will be issued upon separation, and only whole warrants will trade. To separate units, holders must have their brokers contact Continental Stock Transfer & Trust Company, the transfer agent.

Rhea-AI Summary

Bluerock Acquisition Corp. reported that its board of directors appointed Ziv Conen as a Class II director, with a term expiring at the company’s second annual meeting of shareholders. The board determined that he qualifies as an independent director under applicable Nasdaq rules.

The filing highlights Mr. Conen’s background, including his role as a Partner at New Era Capital Partners since September 2021, prior experience as an Associate Partner at McKinsey & Company, and earlier service in Israel’s Unit 8200, where he completed his service with the rank of Major. He holds an MBA from MIT and a B.Sc in Computer Science from the Open University of Israel.

In connection with his appointment, the company entered into an indemnity agreement with Mr. Conen, a letter agreement, and a joinder to a registration rights agreement. He will receive 35,000 Class B ordinary shares of the company from Bluerock Acquisition Holdings, LLC, the sponsor. The company states there are no other arrangements, family relationships, or related-party transactions requiring disclosure related to his appointment.

Rhea-AI Summary

Bluerock Acquisition Corp. has completed its initial public offering of 17,250,000 units, including the full exercise of the underwriters’ over-allotment option. Each unit contains one Class A ordinary share and one-third of a redeemable warrant. The units were sold at $10.00 per unit, generating $172,500,000 in gross proceeds.

The company also completed a simultaneous private placement of 4,500,000 private placement warrants at $1.00 per warrant, raising an additional $4,500,000. A total of $172,500,000 from the IPO and private placement, including up to $7,350,000 of deferred underwriting commission, has been deposited into a U.S.-based trust account for the benefit of public shareholders.

Rhea-AI Summary

Bluerock Acquisition Corp. completed its initial public offering of 17,250,000 units at $10.00 per unit, generating gross proceeds of $172,500,000. Each unit consists of one Class A ordinary share and one-third of a redeemable warrant, with each whole warrant allowing the purchase of one Class A ordinary share at $11.50 after the company completes its initial business combination.

The company also sold 4,500,000 private placement warrants at $1.00 each to its sponsor and the underwriters, raising an additional $4,000,000. A total of $172,500,000 of net proceeds from the IPO and private placement, including up to $7,350,000 of deferred underwriting commissions, was deposited into a U.S.-based trust account, which will fund an initial business combination or redemptions if no deal is completed within 24 months. Bluerock appointed independent directors Peter Cotton and Andrew Weksler, granted them Class B shares as compensation, and adopted a Second Amended and Restated Memorandum and Articles of Association in connection with the IPO.